Prophylaxis with apixaban feasible for cancer patients
(HealthDay) -- Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic ...
Cancer
Mar 29, 2012 |
not rated yet |
0
Alzheimer's drug sharply criticized by medical experts
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food ...
Alzheimer's disease & dementia
Mar 23, 2012 |
5 / 5 (1) |
0
Coffee, caffeine not linked to psoriasis in U.S. women
(HealthDay) -- Coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking, according to a research letter published in the March issue of the Archives of Dermatology.
Diseases, Conditions, Syndromes
Mar 21, 2012 |
not rated yet |
1
|
S. Korea to approve Viagra generics
Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.
Medications
Mar 14, 2012 |
not rated yet |
0
US Pfizer, India's Biocon scrap insulin pact
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Medications
Mar 13, 2012 |
not rated yet |
0
FDA panel supports continued testing of pain drugs
(AP) -- A panel of arthritis experts has recommended that the federal government allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure
Medications
Mar 12, 2012 |
not rated yet |
0
FDA panel to weigh second chance for new class of painkillers
(HealthDay) -- A U.S. Food and Drug Administration advisory panel on Monday will weigh the wisdom of allowing new clinical trials of a class of powerful painkillers for osteoarthritis. The drugs may have worked ...
Medications
Mar 12, 2012 |
not rated yet |
0
Gene-based test identifies poor-prognosis colon cancers
(HealthDay) -- A sensitive and specific gene-based classifier can be used to identify BRAF mutant colon cancer tumors and a subpopulation of BRAF wild-type tumors with poor prognosis, according to a study pu ...
Cancer
Mar 09, 2012 |
5 / 5 (1) |
0
FDA links once-promising pain drugs to bone decay
Some of the world's largest drugmakers will face an uphill battle next week in their bid to revive a class of experimental arthritis drugs that have been sidelined by safety concerns for nearly two years.
Medications
Mar 08, 2012 |
not rated yet |
0
Smoking is an independent risk factor for psoriasis
(HealthDay) -- Smoking is an independent risk factor for psoriasis, with particularly strong associations for heavy smokers and those who have smoked for many years, according to research published in the ...
Inflammatory disorders
Mar 07, 2012 |
5 / 5 (1) |
1
India's global pharmacy role threatened by EU pact
(AP) -- Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted ...
Medications
Feb 10, 2012 |
not rated yet |
0
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medications
Jan 27, 2012 |
5 / 5 (2) |
0
With new generic rivals, Lipitor's sales halved
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Medications
Dec 20, 2011 |
not rated yet |
3
FDA panel backs Pfizer drug for kidney cancer
(AP) -- A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.
Medications
Dec 07, 2011 |
not rated yet |
0
US approves India's Ranbaxy to make generic Lipitor
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.
Medications
Dec 01, 2011 |
5 / 5 (1) |
0
